TY  - GEN
AU  - Jensen,Jens-Ulrik
AU  - Lundgren,Bettina
AU  - Hein,Lars
AU  - Mohr,Thomas
AU  - Petersen,Pernille L
AU  - Andersen,Lasse H
AU  - Lauritsen,Anne O
AU  - Hougaard,Sine
AU  - Mantoni,Teit
AU  - Bømler,Bonnie
AU  - Thornberg,Klaus J
AU  - Thormar,Katrin
AU  - Løken,Jesper
AU  - Steensen,Morten
AU  - Carl,Peder
AU  - Petersen,J Asger
AU  - Tousi,Hamid
AU  - Søe-Jensen,Peter
AU  - Bestle,Morten
AU  - Hestad,Søren
AU  - Andersen,Mads H
AU  - Fjeldborg,Paul
AU  - Larsen,Kim M
AU  - Rossau,Charlotte
AU  - Thomsen,Carsten B
AU  - Ostergaard,Christian
AU  - Kjaer,Jesper
AU  - Grarup,Jesper
AU  - Lundgren,Jens D
TI  - The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients
SN  - 1471-2334
PY  - 2008///1118
KW  - Adolescent
KW  - Adult
KW  - Biomarkers
KW  - blood
KW  - Calcitonin
KW  - Calcitonin Gene-Related Peptide
KW  - Critical Illness
KW  - mortality
KW  - Female
KW  - Humans
KW  - Intensive Care Units
KW  - Male
KW  - Protein Precursors
KW  - Sepsis
KW  - diagnosis
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1186/1471-2334-8-91
ER  -